Plaque

A Cutting-Edge Scientific Approach to Cholesterol Control, Weight Control and Disease Prevention With Less Dietary Restriction

Retrieved on: 
Giovedì, Maggio 2, 2024
Selenium, Blood, Nitrite, Stroke, Cell, Weight gain, Risk, Burn, Isoflavone, Pancreatic cancer, Blood pressure, Publication, Health, Common carotid artery, Heart, Nitrosamine, Breast, Publishing, Moyamoya disease, Human, Rib, Water, Freedom, Dietary fiber, Fat, Obesity, Potassium, Vitamin, ISBN, Diet, Dietary Reference Intake, Sodium, Cholesterol, Food, Homocysteine, Folate, Antioxidant, Neoplasm, Wiley (publisher), Fruit, Vegetable, Artery, Absorption, Lipid, Plaque, Growth, Dietary supplement

CHICAGO, May 2, 2024 /PRNewswire-PRWeb/ -- Junk food is so loved by many. What is not loved are the associated medical conditions and weight gain. Over time, scientific studies have been conducted at various institutions across America and abroad. These studies have indicated that fiber and antioxidants can mitigate the health risks associated with junk food by counteracting the physiological effects of high-fat and other junk food, thus offering a cutting-edge approach to maintaining better health without deprivation. This does not mean that π‘’π‘›π‘™π‘–π‘šπ‘–π‘‘π‘’π‘‘ consumption of junk food without consequences is now possible. What it does mean is greater freedom, less restriction and a wider variety of food choices for π˜©π‘’π‘Žπ‘™π‘‘π˜©π‘¦ individuals. These groundbreaking discoveries are uncovered in the book πΆπ‘œπ‘’π‘›π‘‘π‘’π‘Ÿπ‘Žπ‘π‘‘ π‘‘π˜©π‘’ πΉπ‘Žπ‘‘: π»π‘œπ‘€ 𝑆𝑐𝑖𝑒𝑛𝑑𝑖𝑓𝑖𝑐 𝑆𝑑𝑒𝑑𝑖𝑒𝑠 π»π‘Žπ‘£π‘’ π‘†π˜©π‘œπ‘€π‘› π‘‡π˜©π‘Žπ‘‘ πΉπ‘–π‘π‘’π‘Ÿ π‘Žπ‘›π‘‘ π΄π‘›π‘‘π‘–π‘œπ‘₯π‘–π‘‘π‘Žπ‘›π‘‘π‘  πΆπ‘Žπ‘› πΆπ‘œπ‘’π‘›π‘‘π‘’π‘Ÿπ‘Žπ‘π‘‘ π‘‘π˜©π‘’ π‘ƒπ˜©π‘¦π‘ π‘–π‘œπ‘™π‘œπ‘”π‘–π‘π‘Žπ‘™ 𝐸𝑓𝑓𝑒𝑐𝑑𝑠 π‘œπ‘“ π½π‘’π‘›π‘˜ πΉπ‘œπ‘œπ‘‘ π‘Žπ‘›π‘‘ π‘ƒπ‘Ÿπ‘œπ‘šπ‘œπ‘‘π‘’ πΆπ˜©π‘œπ‘™π‘’π‘ π‘‘π‘’π‘Ÿπ‘œπ‘™ π‘Žπ‘›π‘‘ π‘Šπ‘’π‘–π‘”π˜©π‘‘ πΆπ‘œπ‘›π‘‘π‘Ÿπ‘œπ‘™ π‘Šπ‘–π‘‘π˜© 𝐿𝑒𝑠𝑠 π‘…π‘’π‘ π‘‘π‘Ÿπ‘–π‘π‘‘π‘–π‘œπ‘› (ISBN: 979-8398923704). The following concepts are discussed in the book:

Key Points: 
  • What it does mean is greater freedom, less restriction and a wider variety of food choices for π˜©π‘’π‘Žπ‘™π‘‘π˜©π‘¦ individuals.
  • According to scientists, beta glucans can reduce the absorption of dietary fats and promote cholesterol control all by itself, even in a diet containing moderate amounts of saturated fat and cholesterol.
  • Scientists have reported that fiber helps to promote weight control by reducing the amount of calories the body absorbs .
  • Scientists have also reported that antioxidants help to promote weight control by providing the body with the energy that it needs to burn fat more efficiently .

The Deputy Prime Minister of the United Arab Emirates delivered the closing remarks at the UCAM - DIHAD Master's Degree in Sustainable Humanitarian Action

Retrieved on: 
Giovedì, Maggio 2, 2024
INDEX, Hope, Business, Ministry of home affairs, Master, Ahmad, Multimedia, Non-governmental organization, Faculty, Student, Plaque, Nursing

MURCIA, Spain, May 2, 2024 /PRNewswire/ -- TheΒ Universidad CatΓ³lica de Murcia (UCAM) and the DIHAD Foundation (Dubai International Humanitarian Aid and Development) recently celebrated the graduation ceremony of the first two classes of the Master's Degree in Sustainable Humanitarian Action.Β This innovative degree programme, which has the support and sponsorship of the Ahmad bin Zayed Al Nahyan Foundation and INDEX Holding, combines online and onsite teaching methods and in its first two editions has trained 63 students from 50 nationalities, such as Syria, Nigeria, Iraq, United Arab Emirates, Egypt, Gambia, Malawi, Romania, France, Sudan, Ghana, Lesotho, Ethiopia, South Sudan, Algeria, Kenya, Colombia, Panama and Bangladesh, among others.

Key Points: 
  • MURCIA, Spain, May 2, 2024 /PRNewswire/ -- TheΒ Universidad CatΓ³lica de Murcia (UCAM) and the DIHAD Foundation (Dubai International Humanitarian Aid and Development) recently celebrated the graduation ceremony of the first two classes of the Master's Degree in Sustainable Humanitarian Action .
  • The Master's Degree in Sustainable Humanitarian Action is a unique programme, where students are trained by a multinational faculty with extensive experience and benefit from networking opportunities with humanitarian organisations thanks to the DIHAD Foundation, a federation that brings together more than 600 NGOs worldwide.
  • The programme is designed to introduce students to the latest innovations and technologies in the humanitarian field, enabling them to further their careers in this sector.
  • This graduation marks an important milestone in the lives of these students, who are now prepared to implement, improve and design humanitarian projects and programmes from a sustainable perspective, as well as to lead international organisations.

The Deputy Prime Minister of the United Arab Emirates delivered the closing remarks at the UCAM - DIHAD Master's Degree in Sustainable Humanitarian Action

Retrieved on: 
Giovedì, Maggio 2, 2024
INDEX, Hope, Business, Ministry of home affairs, Master, Ahmad, Non-governmental organization, Faculty, Student, Plaque, Nursing

MURCIA, Spain, May 2, 2024 /PRNewswire/ -- TheΒ Universidad CatΓ³lica de Murcia (UCAM) and the DIHAD Foundation (Dubai International Humanitarian Aid and Development) recently celebrated the graduation ceremony of the first two classes of the Master's Degree in Sustainable Humanitarian Action.Β This innovative degree programme, which has the support and sponsorship of the Ahmad bin Zayed Al Nahyan Foundation and INDEX Holding, combines online and onsite teaching methods and in its first two editions has trained 63 students from 50 nationalities, such as Syria, Nigeria, Iraq, United Arab Emirates, Egypt, Gambia, Malawi, Romania, France, Sudan, Ghana, Lesotho, Ethiopia, South Sudan, Algeria, Kenya, Colombia, Panama and Bangladesh, among others.

Key Points: 
  • MURCIA, Spain, May 2, 2024 /PRNewswire/ -- TheΒ Universidad CatΓ³lica de Murcia (UCAM) and the DIHAD Foundation (Dubai International Humanitarian Aid and Development) recently celebrated the graduation ceremony of the first two classes of the Master's Degree in Sustainable Humanitarian Action .
  • The Master's Degree in Sustainable Humanitarian Action is a unique programme, where students are trained by a multinational faculty with extensive experience and benefit from networking opportunities with humanitarian organisations thanks to the DIHAD Foundation, a federation that brings together more than 600 NGOs worldwide.
  • The programme is designed to introduce students to the latest innovations and technologies in the humanitarian field, enabling them to further their careers in this sector.
  • This graduation marks an important milestone in the lives of these students, who are now prepared to implement, improve and design humanitarian projects and programmes from a sustainable perspective, as well as to lead international organisations.

A Cutting-Edge Scientific Approach to Cholesterol Control, Weight Control and Disease Prevention With Less Dietary Restriction

Retrieved on: 
Mercoledì, Maggio 1, 2024
Selenium, Blood, Nitrite, Stroke, Cell, Weight gain, Risk, Burn, Isoflavone, Pancreatic cancer, Blood pressure, Publication, Health, Common carotid artery, Heart, Nitrosamine, Breast, Publishing, Moyamoya disease, Human, Rib, Water, Freedom, Dietary fiber, Fat, Obesity, Potassium, Vitamin, ISBN, Diet, Dietary Reference Intake, Sodium, Cholesterol, Food, Homocysteine, Folate, Antioxidant, Neoplasm, Multimedia, Wiley (publisher), Fruit, Vegetable, Artery, Absorption, Lipid, Plaque, Growth, Dietary supplement

CHICAGO, May 1, 2024 /PRNewswire-PRWeb/ -- Junk food is so loved by many. What is not loved are the associated medical conditions and weight gain. Over time, scientific studies have been conducted at various institutions across America and abroad. These studies have indicated that fiber and antioxidants can mitigate the health risks associated with junk food by counteracting the physiological effects of high-fat and other junk food, thus offering a cutting-edge approach to maintaining better health without deprivation. This does not mean that π‘’π‘›π‘™π‘–π‘šπ‘–π‘‘π‘’π‘‘ consumption of junk food without consequences is now possible. What it does mean is greater freedom, less restriction and a wider variety of food choices for π˜©π‘’π‘Žπ‘™π‘‘π˜©π‘¦ individuals. These groundbreaking discoveries are uncovered in the book πΆπ‘œπ‘’π‘›π‘‘π‘’π‘Ÿπ‘Žπ‘π‘‘ π‘‘π˜©π‘’ πΉπ‘Žπ‘‘: π»π‘œπ‘€ 𝑆𝑐𝑖𝑒𝑛𝑑𝑖𝑓𝑖𝑐 𝑆𝑑𝑒𝑑𝑖𝑒𝑠 π»π‘Žπ‘£π‘’ π‘†π˜©π‘œπ‘€π‘› π‘‡π˜©π‘Žπ‘‘ πΉπ‘–π‘π‘’π‘Ÿ π‘Žπ‘›π‘‘ π΄π‘›π‘‘π‘–π‘œπ‘₯π‘–π‘‘π‘Žπ‘›π‘‘π‘  πΆπ‘Žπ‘› πΆπ‘œπ‘’π‘›π‘‘π‘’π‘Ÿπ‘Žπ‘π‘‘ π‘‘π˜©π‘’ π‘ƒπ˜©π‘¦π‘ π‘–π‘œπ‘™π‘œπ‘”π‘–π‘π‘Žπ‘™ 𝐸𝑓𝑓𝑒𝑐𝑑𝑠 π‘œπ‘“ π½π‘’π‘›π‘˜ πΉπ‘œπ‘œπ‘‘ π‘Žπ‘›π‘‘ π‘ƒπ‘Ÿπ‘œπ‘šπ‘œπ‘‘π‘’ πΆπ˜©π‘œπ‘™π‘’π‘ π‘‘π‘’π‘Ÿπ‘œπ‘™ π‘Žπ‘›π‘‘ π‘Šπ‘’π‘–π‘”π˜©π‘‘ πΆπ‘œπ‘›π‘‘π‘Ÿπ‘œπ‘™ π‘Šπ‘–π‘‘π˜© 𝐿𝑒𝑠𝑠 π‘…π‘’π‘ π‘‘π‘Ÿπ‘–π‘π‘‘π‘–π‘œπ‘› (ISBN: 979-8398923704). The following concepts are discussed in the book:

Key Points: 
  • What it does mean is greater freedom, less restriction and a wider variety of food choices for π˜©π‘’π‘Žπ‘™π‘‘π˜©π‘¦ individuals.
  • According to scientists, beta glucans can reduce the absorption of dietary fats and promote cholesterol control all by itself, even in a diet containing moderate amounts of saturated fat and cholesterol.
  • Scientists have reported that fiber helps to promote weight control by reducing the amount of calories the body absorbs .
  • Scientists have also reported that antioxidants help to promote weight control by providing the body with the energy that it needs to burn fat more efficiently .

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee

Retrieved on: 
Lunedì, Aprile 29, 2024
Stent, FDA, Leg, Education, Physician, Knee, Esprit, TCT, Everolimus, Food, PAD, Survival rate, Breast, Columbia University, Conference, Foot, Disease, Amputation, Oxygen, Standard of care, Artery, Plaque, Peripheral artery disease, BTK, CLTI, Pharmaceutical industry

The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.

Key Points: 
  • The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
  • Until today, there were no stents or drug-coated balloons approved for use below the knee in the U.S.
  • The Esprit BTK System is a first-of-its-kind dissolvable stent and is comprised of material similar to dissolving sutures.
  • That's why we're revolutionizing treatments with resorbable scaffold technology below the knee," said Julie Tyler, senior vice president of Abbott's vascular business.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX

Retrieved on: 
Mercoledì, Aprile 24, 2024
Prospectus, Action Replay, LLP, Person, Prior, News, Complaint, Security (finance), Pomerantz, Form, IPO, District court, Defendant, Court, Ext, Psoriasis, Inflammation, Register, Plaque, File

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (β€œVentyx” or the β€œCompany”) (NASDAQ: VTYX) and certain officers.

Key Points: 
  • NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (β€œVentyx” or the β€œCompany”) (NASDAQ: VTYX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Martedì, Aprile 23, 2024
Prospectus, Person, News, Complaint, IPO, Defendant, Court, Psoriasis, Inflammation, Plaque, Pharmaceutical industry

Ventyx is a clinical-stage biopharmaceutical company that develops small molecule product candidates to address a range of inflammatory diseases.

Key Points: 
  • Ventyx is a clinical-stage biopharmaceutical company that develops small molecule product candidates to address a range of inflammatory diseases.
  • The Company’s lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn’s disease.
  • On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease

Retrieved on: 
Lunedì, Aprile 22, 2024
Amyloid, Alzheimer's disease, Jort, University, MCI, Inflammation, Oxidative stress, ARIA, News, Research, Neuroinflammation, Cognition, Doctor of Philosophy, ADAS, START, KOL, Patient, SHINE, Perception, Neuron, Antibody, Therapy, Plaque, Cerebrospinal fluid

β€œThe KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers who highlighted the need to find Alzheimer’s disease treatments that are less burdensome for patients and their care partners,” said Lisa Ricciardi, Cognition’s president and CEO .

Key Points: 
  • β€œThe KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers who highlighted the need to find Alzheimer’s disease treatments that are less burdensome for patients and their care partners,” said Lisa Ricciardi, Cognition’s president and CEO .
  • The SHINE studyΒ enrolled participants in the U.S. and several countries in Europe including The Netherlands.
  • Dr. Vijverberg reviewed the design of the SHINE study and the results of the preliminary analysis of the first 24 patients who finished six months of treatment.
  • An archive of the KOL roundtable discussion is available on the News & Events page of the Investors section of the Cognition website or may be accessed directly at the following URL: https://lifescievents.com/event/cognition/ .

VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx Biosciences, Inc. Investors of Upcoming Deadline

Retrieved on: 
Lunedì, Aprile 22, 2024
News, Complaint, IPO, Action Replay, District court, Defendant, Court, Psoriasis, Inflammation, Plaque, Advertising, Security (finance)

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)?
  • If you purchased or acquired Ventyx securities, including pursuant to the IPO, and/or would like to discuss your legal rights and options please visit Ventyx Biosciences, Inc.
  • On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

VTYX INVESTOR ALERT: Kirby McInerney LLP Alerts Ventyx Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

Retrieved on: 
Giovedì, Aprile 18, 2024
News, IPO, District court, Psoriasis, Plaque, TYK2, Pharmaceutical industry

The firm encourages investors to contact the firm by April 30, 2024 to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • The firm encourages investors to contact the firm by April 30, 2024 to be appointed as lead plaintiff in the lawsuit.
  • From the start of the Class Period on October 21, 2021, Ventyx issued numerous press releases containing positive news and results from its development of VTX958, a novel TYK2 inhibitor.
  • On November 6, 2023, Ventyx issued a press release announcing results from its Phase 2 SERENITY Trial.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.